Duke University Eye Center
Durham, North Carolina, 27710, United States
Location status: Recruiting
Location contact
Anthony Kuo, MD
SUB_INVESTIGATOR
Hafeez Dhalla, PhD
SUB_INVESTIGATOR
Michelle N McCall, MCAPM, BA
CONTACT
Neeru Sarin, MD
CONTACT
NCT Number: NCT06841575
The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adult volunteers, and adult and pediatric patients in clinic.
Interested in participating?
Request Info1 month and older
All sexes
Interventional
Not applicable
Durham, North Carolina, 27710, United States
Location status: Recruiting
Anthony Kuo, MD
SUB_INVESTIGATOR
Hafeez Dhalla, PhD
SUB_INVESTIGATOR
Michelle N McCall, MCAPM, BA
CONTACT
Neeru Sarin, MD
CONTACT
Handheld OCT imaging is an advancement in ophthalmic imaging technology allowing us to image the pediatric retina. lt has tremendous potential to be applied to assess the structure and blood flow of children with retinal vascular diseases or as a screening tool for pediatric retinal diseases. Despite progress in the development of hand-held OCT probes, there remains a critical gap in technology to achieve fast, proper alignment between the imaging device and the infant eye. Even with the most skilled operators, to acquire consistent OCT and OCTA data capture for longitudinal follow up in uncooperative patients at the bedside remains difficult. lmprovements in hand-held OCT probe technology for auto-alignment to the patient's eye, as well as on-line detection of image quality and auto-saving at the proper time, would address this critical gap in handheld OCT technology. Our biomedical engineering team, has developed prior iterations of the handheld OCT devices and successfully imaged the pediatric retina. The goal of the current study is to conduct a pilot study to test a new version of the handheld OCT device capable of auto-alignment to image the retina in adult volunteers, and adult and pediatric patients in clinic.
The investigators plan to enroll 20 healthy adult volunteers, 20 adult patients and 10 pediatric patients from the ophthalmology clinic. This is an observational study. There are no known risks associated with handheld OCT imaging and no adverse events identified imaging with prior iterations of handheld OCT devices. lmaging data will be downloaded to a secure server for protocol image processing, segmentation, and analysis per protocol in the Duke Advanced Research in SS/SDOCT lmaging (DARSI) laboratory.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Swept Source OCT system with improved hand-held probe technology for auto-alignment to the patient's eye, as well as on-line detection of image quality and auto-saving at the proper time
Time frame: Up to 4 single imaging sessions at clinical visits over 2 years
Measured by optical coherence tomography (OCT) reading.
Time frame: Up to 4 single imaging sessions at clinical visits over 2 years
Measured by optical coherence tomography (OCT) reading.
Time frame: Up to 4 single imaging sessions at clinical visits over 2 years
Measured by optical coherence tomography (OCT) analysis.
Contact information is provided by the study sponsor or research team.
Michelle N McCall, MCAPM, BA
CONTACT
Xi Chen, MD, PhD
CONTACT
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06891443
Blindness, Congenital Abnormalities
San Francisco, California, United States
View Trial DetailsNCT04232982
Cornea Disease, Corneal Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT06934577
Eye Diseases, Glaucoma
Flint, Michigan, United States
View Trial DetailsNCT06394232
Age-Related Macular Degeneration, Eye Diseases
Jālna, Maharashtra, India
View Trial Details